leadf
logo-loader
viewQrons Inc.

Full interview: Qrons seeking to find a cure for traumatic brain injuries using a 3D-printable scaffold

Qrons Inc (OTCQB: QRON) CEO Jonah Meer tells Proactive the New York-based biotechnology company is developing two products, one of which involves a 3D-printable scaffold, aimed at helping to treat traumatic brain injuries.

Meer says that traumatic brain injuries are the number one cause of death among young adults in the US, adding that the company is working towards an Investigational New Drug application or a Biologics Licence application for its products to the FDA.

Quick facts: Qrons Inc.

Price: 0.39 USD

OTCMKTS:QRON
Market: OTCQB
Market Cap: $5.18 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

CO2 GRO sees 20% higher pepper yields though 10 weeks of Hidroexpo Feasibility

CO2 GRO (CVE: GROW- OTCQB: BLONF) Vice President of Sales and Strategic Alliances Aaron Archibald joined Steve Darling from Proactive to bring details the company has seen very good results from their CO2 Delivery Solution commercial feasibility on greenhouse-grown peppers with Hidroexpo in...

2 days, 8 hours ago

2 min read